C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/11 (2006.01) A61K 31/70 (2006.01) C07H 21/04 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2283626
Disclosed are synthetic, modified oligonucleotides complementary to, and capable of down-regulating the expression of, nucleic acid encoding protein kinase A subunit RI.alpha.. The modified oligonucleotides have from about 15 to about 30 nucleotides and are hybrid, inverted hybrid, or inverted chimeric oligonucleotides. Also disclosed are therapeutic compositions containing such oligonucleotides and methods of using the same.
L'invention concerne des oligonucléotides modifiés synthétiques, qui complètent l'acide nucléique codant la sous-unité RI¿.alpha.? de la protéine kinase A, et peuvent rétro-réguler l'expression dudit acide nucléique. Lesdits oligonucléotides modifiés contiennent entre environ 15 et 30 nucléotides et sont des oligonucléotides hybrides, hybrides inversés ou chimériques inversés. L'invention concerne en outre des compositions thérapeutiques contenant lesdits oligonucléotides et des méthodes d'utilisation associées.
Hybridon Inc.
Mbm Intellectual Property Law Llp
LandOfFree
Modified protein kinase a-specific oligonucleotides and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified protein kinase a-specific oligonucleotides and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified protein kinase a-specific oligonucleotides and... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1908440